Cleared Traditional

K180216 - Seidmon Antegrade AQ Stent Set

K180216 is the FDA 510(k) clearance for Seidmon Antegrade AQ Stent Set by Cook Incorporated. It is a Class 2 Gastroenterology & Urology device (product code FAD) cleared through the Traditional 510(k) pathway after a 246-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2018
Decision
246d
Days
Class 2
Risk

K180216 is an FDA 510(k) clearance for the Seidmon Antegrade AQ Stent Set. Classified as Stent, Ureteral (product code FAD), Class II - Special Controls.

Submitted by Cook Incorporated (Bloomington, US). The FDA issued a Cleared decision on September 28, 2018 after a review of 246 days - an extended review cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.4620 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Cook Incorporated devices

Submission Details

510(k) Number K180216 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 25, 2018
Decision Date September 28, 2018
Days to Decision 246 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
116d slower than avg
Panel avg: 130d · This submission: 246d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FAD Stent, Ureteral
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.4620
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FAD Stent, Ureteral

All 74
Devices cleared under the same product code (FAD) and FDA review panel - the closest regulatory comparables to K180216.
Bander Ureteral Diversion Stent Set, Dretler Ureteroscopy Stent Set
K181971 · Cook Incorporated · Apr 2019
Greene Renal Transplant Stent Set
K180557 · Cook Incorporated · Nov 2018
ImaJin Silicone Hydro-Coated Double Loop Ureteral Stent
K180469 · Coloplast Corp. · Nov 2018
Malecot Nephrostomy Catheter/Stent Set
K180029 · Cook Incorporated · Sep 2018
Sof-Flex Ureteral Stent Set
K180053 · Cook Incorporated · Sep 2018
Cope Nephroureterostomy Stent and Amplatz Ureteral Stent Set
K171603 · Cook Incorporated · Apr 2018